CPHI vs OGN · rev $4.1M vs P/E 3.4, rev $6.40B
China Pharma Holdings Inc (CPHI) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
CPHI currently screens at market cap $29.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the CPHI and OGN stock pages for the full models.
Not investment advice.